ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors.

Saoirse O Dolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.